Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meora Feinmesser

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancer Immunology Research|April 18, 2023
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid TumorsDiana Rasoulouniriana, Nadine Santana-Magal, Amit Gutwillig, et al.
Cancer Research|March 5, 2020
Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer ImmunotherapyNadine Santana-Magal, Leen Farhat-Younis, Amit Gutwillig, et al.
Oncotarget|September 23, 2015
The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growthMichal Hameiri-Grossman, Adi Porat-Klein, Isaac Yaniv, et al.
Genes, Chromosomes & Cancer|April 25, 2017
Prognostic relevance of miR-124-3p and its target TP53INP1 in pediatric ependymomaYulia Margolin-Miller, Natalia Yanichkin, Keren Shichrur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 30, 2010
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue originShai Rosenwald, Shlomit Gilad, Sima Benjamin, et al.
The Journal of Molecular Diagnostics : JMD|July 4, 2012
Classification of the four main types of lung cancer using a microRNA-based diagnostic assayShlomit Gilad, Gila Lithwick-Yanai, Iris Barshack, et al.
The Oncologist|May 24, 2012
A second-generation microRNA-based assay for diagnosing tumor tissue originEti Meiri, Wolf C Mueller, Shai Rosenwald, et al.
Elife|September 20, 2022
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapyAmit Gutwillig, Nadine Santana-Magal, Leen Farhat-Younis, et al.
Scientific Reports|June 29, 2021
Generation of vascular chimerism within donor organsShahar Cohen, Shirly Partouche, Michael Gurevich, et al.
Cell|March 19, 2022
Tumor-reactive antibodies evolve from non-binding and autoreactive precursorsRoei D Mazor, Nachum Nathan, Amit Gilboa, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer Immunology Research|April 18, 2023
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid TumorsDiana Rasoulouniriana, Nadine Santana-Magal, Amit Gutwillig, et al.
Cancer Research|March 5, 2020
Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer ImmunotherapyNadine Santana-Magal, Leen Farhat-Younis, Amit Gutwillig, et al.
Oncotarget|September 23, 2015
The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growthMichal Hameiri-Grossman, Adi Porat-Klein, Isaac Yaniv, et al.
Genes, Chromosomes & Cancer|April 25, 2017
Prognostic relevance of miR-124-3p and its target TP53INP1 in pediatric ependymomaYulia Margolin-Miller, Natalia Yanichkin, Keren Shichrur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 30, 2010
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue originShai Rosenwald, Shlomit Gilad, Sima Benjamin, et al.
The Journal of Molecular Diagnostics : JMD|July 4, 2012
Classification of the four main types of lung cancer using a microRNA-based diagnostic assayShlomit Gilad, Gila Lithwick-Yanai, Iris Barshack, et al.
The Oncologist|May 24, 2012
A second-generation microRNA-based assay for diagnosing tumor tissue originEti Meiri, Wolf C Mueller, Shai Rosenwald, et al.
Elife|September 20, 2022
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapyAmit Gutwillig, Nadine Santana-Magal, Leen Farhat-Younis, et al.
Scientific Reports|June 29, 2021
Generation of vascular chimerism within donor organsShahar Cohen, Shirly Partouche, Michael Gurevich, et al.
Cell|March 19, 2022
Tumor-reactive antibodies evolve from non-binding and autoreactive precursorsRoei D Mazor, Nachum Nathan, Amit Gilboa, et al.
Pageof 8